If an abstract was sent in and it contained no new data then disappointment would prevail.
If an abstract was sent in and it contained new data then company would be accused of insider information release.. Not being publicly released..
If no abstract then a Press Release could be done Monday and thus fair information release as
well as being able to be talked about at symposium.
just a wag
All data is known to company and to their market makers or suitors.
If not directly then by inference of anecdotal observations.
It is a question of authentication.
With Newlink Genetics they were unloading stock knowing bad news was expected.
With Anavex they are buying stock knowing that good news is expected
I think that the shorties are beating this down to cover their positions but are finding that the longs
are not going to sell because of the perceived future value.
So they beat harder...
Many of the cutting edge bios are being shaken because of pending 21st Century Cures Act.
NWBO is another example.. A cancer cure without the horrible side effects.
Idiot 43 and Christopher Cox took away the uptick rule and the small investor has suffered ever since.
Sentiment: Strong Buy
Lets not forget the Alberta fire.. A tragedy...
My guess is that many individuals needed cash so they withdrew from
mutual funds. Like wise insurance companies would need to raise cash and sell some holdings. Electrovaya being a thinly traded stock would
be disproportionately effected. They still have the best battery technology jmho
Italy meeting is a Symposium...
Symposium: a meeting or conference for the discussion of some subject, especially a meeting at which several speakers talk on or discuss a topic before an audience.
Conference: a meeting for consultation or discussion: a conference between a student and his adviser
Seems science-y to me..
Destroy them all by having the SEC re-implement the uptick rule but this time base it on the
prior day's close.
What are the chances that the good Dr will show up to a Science Conference with nothing to say?
Small chance that he will say "The third party accountant dogs ate my homework"
They seem desperate to accumulate or cover their shorts ahead of great news.
Sentiment: Strong Buy
I believe that the Zika virus and the passage of the 21st Century Cures Act will shorten the time line
to revenues in the US revenues. Remember that Zika is a tropical disease and those countries are more likely to be quick adopters. CERS has international marketing and is using it.
Any ideas concerning this.. Amount guesses if any...
If they are substantial then dilution would seem less likely.
Maybe part of the take down is related to them buying shares.
Perhaps final agreements will be made in 3 weeks.
The Company has reached conceptual agreement with three different sets of parties, in regard to three different combination treatments, for three different cancers in three different Phase II trials. These involve leading participants in the immunotherapy field. The Company and these parties are now completing the agreements and budgets, and pursuing regulatory approval for the agreed upon trials.
As of Dec 31, 2016 institutions and mutual funds owned 63%.. If osir is going below 5, they would
need a way out to remain in the sector.
Just a guess but from PRs and OSIR corporate troubles would make sense.
As soon as they are done, the back to 12.
Perhaps a poor choice of nouns, but in today's litigious environment whoever they are,
they are most likely protected by a corporate shield. Any arguments that NWBO is pulling
the wool over someone's eyes is now invalid.